Title : A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN.

Pub. Date : 2004 Aug 15

PMID : 15261564






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN. Cyclophosphamide interferon beta 1 Homo sapiens